First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Reaches New 12-Month High – What’s Next?

Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBTGet Free Report) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $229.55 and last traded at $229.1060, with a volume of 1277 shares traded. The stock had previously closed at $226.42.

First Trust NYSE Arca Biotechnology Index Fund Trading Up 1.8%

The stock has a 50-day simple moving average of $212.20 and a 200-day simple moving average of $209.43. The company has a market cap of $2.60 billion, a price-to-earnings ratio of 21.72 and a beta of 0.68.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. First Trust Advisors LP raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 49,660.7% in the 1st quarter. First Trust Advisors LP now owns 3,515,093 shares of the company’s stock worth $705,900,000 after buying an additional 3,508,029 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 4,370.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 577,231 shares of the company’s stock worth $119,210,000 after buying an additional 564,319 shares in the last quarter. 360 Financial Inc. bought a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter worth $14,887,000. Stonebridge Financial Group LLC bought a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter worth $14,734,000. Finally, Morgan Stanley raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 18.2% in the 4th quarter. Morgan Stanley now owns 401,201 shares of the company’s stock worth $82,856,000 after buying an additional 61,755 shares in the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

(Get Free Report)

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.

Featured Stories

Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.